Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:ZSAN

Zosano Pharma (ZSAN) Stock Price, News & Analysis

Zosano Pharma logo

About Zosano Pharma Stock (NASDAQ:ZSAN)

Advanced Chart

Key Stats

Today's Range
$0.0002
$0.0002
50-Day Range
$0.52
$112.00
52-Week Range
$0.46
$37.45
Volume
5,685 shs
Average Volume
425,375 shs
Market Capitalization
$980.40
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive ZSAN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Zosano Pharma and its competitors with MarketBeat's FREE daily newsletter.

ZSAN Stock News Headlines

Aktuelle Empfehlungen zur ZOSANO
The Trump Dump is starting; Get out of stocks now?
The first 365 days of the Trump presidency… Will be the best time to get rich in American history.
HOOK HOOKIPA Pharma Inc.
East Bay Business News
Astellas Pharma
Zosano Pharma Corporation (ZSANQ)
See More Headlines

ZSAN Stock Analysis - Frequently Asked Questions

Zosano Pharma Co. (NASDAQ:ZSAN) released its earnings results on Friday, May, 13th. The biotechnology company reported ($1.76) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($1.75) by $0.01. Zosano Pharma had a negative net margin of 8,375.11% and a negative trailing twelve-month return on equity of 177.06%.

Zosano Pharma's stock reverse split before market open on Tuesday, April 12th 2022.The 1-35 reverse split was announced on Tuesday, April 12th 2022. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, April 12th 2022. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split.

Zosano Pharma (ZSAN) raised $47 million in an IPO on Tuesday, January 27th 2015. The company issued 4,300,000 shares at a price of $10.00-$12.00 per share. Ladenburg Thalmann and Roth Capital Partners served as the underwriters for the IPO.

Based on aggregate information from My MarketBeat watchlists, some other companies that Zosano Pharma investors own include Tonix Pharmaceuticals (TNXP), NIO (NIO), Adamis Pharmaceuticals (ADMP), Bionano Genomics (BNGO), NightHawk Biosciences (NHWK), Sorrento Therapeutics (SRNE) and Aeterna Zentaris (AEZS).

Company Calendar

Last Earnings
5/13/2022
Today
7/13/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:ZSAN
CIK
1587221
Fax
N/A
Employees
40
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($14.5034)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$29.92 million
Net Margins
-8,375.11%
Pretax Margin
-8,375.11%
Return on Equity
-177.06%
Return on Assets
-119.14%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
1.61
Quick Ratio
1.61

Sales & Book Value

Annual Sales
$790 thousand
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$9.74 per share
Price / Book
0.00

Miscellaneous

Outstanding Shares
4,902,000
Free Float
4,784,000
Market Cap
$980.40
Optionable
Not Optionable
Beta
3.30

Social Links

Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

This page (NASDAQ:ZSAN) was last updated on 7/13/2025 by MarketBeat.com Staff
From Our Partners